Epstein Secrets

who robbed 3 different banks" in Colorado. The suspect is known as the "Double Dipper Bandit." Rhode Island Man Charged With Drug Trafficking. The Providence (RI) Journal (7/7, 259K) reports Franklin Carlos Soto, who "was deported to the Dominican Republic in 2015 after illegally entering the country two

shown to be effective in clinical trials." CNN (7/7, Cohen, Bonifield, 83.16M) reports on its website that Novavax CEO/President Stanley Erck "said Novavax's vaccine could be on the market by the first quarter of next year." The Hill (7/7, Budryk, 2.98M) reports that "the award will also cover a large-

rnment To Pay $1.6B For Rush Vaccine Development. The CBS Evening NewsVi (7/7, story 3, 1:40, O'Donnell, 4.24M) reported, "Maryland biotech company Novavax is in the hunt for a coronavirus vaccine, and getting a major dose of funding from the government's Operation Warp Speed program." The New York lime

ty by fraudulent pretenses, representations or promises from two elder victims." US Charges Nine With Stealing, Selling Boats, Other Vehicles. The Providence (RI) Journal <https://www.providencejoumal.cotn/story/news/crime/2020/11/23/9-indicted- stealing-boats-atvs-excavators-ri-3-other-states/6395140002/>

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

ty by fraudulent pretenses, representations or promises from two elder victims." US Charges Nine With Stealing, Selling Boats, Other Vehicles. The Providence (RI) Journal (11/23, Perry, 259K) reports, "Nine people have been indicted in schemes to steal and sell nearly $700,000 worth of sport boats, excava

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin